Advancing Clinical Trial Design with Bayesian Statistics and Prior Elicitation

1 minute read

Published: April 1st, 2025

Discover how Bayesian statistics can enhance clinical trial efficiency and improve decision-making. Our latest white paper, authored by Giles Partington, Consultant Statistician at Phastar, explores how Bayesian methods address key challenges in clinical research. 

Key insights include:

  • How Bayesian frameworks differ from traditional frequentist approaches
  • The role of prior elicitation in enhancing trial design
  • Practical examples of Bayesian methods in action
  • How Bayesian approaches support rare disease and small population trials
  • Insights into adaptive designs, dose optimization, and sample size calculations

Learn how Bayesian techniques can help refine decision-making, optimize trial designs, and improve outcomes. Download the white paper now to gain valuable insights into implementing Bayesian strategies in your clinical trials.

Related articles

Leveraging Real-World Data for in-silico Trials: Enhancing Clinical Development and Regulatory Confidence

Leveraging Real-World Data for in-silico Trials: Enhancing Clinical Development and Regulatory Confidence

December 3rd, 2025 1 minute read

As the pharmaceutical landscape evolves, traditional clinical trial designs are increasingly complemented by innovati...

Unlock the Power of Real-World Evidence in Clinical Research

Unlock the Power of Real-World Evidence in Clinical Research

February 25th, 2025 1 minute read

Discover how Real-World Evidence (RWE) is revolutionizing drug development and clinical decision-making in our latest...

A Strategic Approach to Project Optimus: Key Considerations for Oncology Trials

A Strategic Approach to Project Optimus: Key Considerations for Oncology Trials

October 10th, 2024 1 minute read

As oncology drug development continues to evolve, the FDA’s Project Optimus is reshaping how clinical trials ap...